These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18582929)

  • 21. [New anticoagulants: dabigatran, rivaroxaban and apixaban].
    Vargas Ruiz AG; Ramírez López AN; Medina Viramontes ME
    Gac Med Mex; 2012; 148(3):257-64. PubMed ID: 22820359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal.
    Stevenson M; Scope A; Holmes M; Rees A; Kaltenthaler E
    Health Technol Assess; 2009 Oct; 13 Suppl 3():43-8. PubMed ID: 19846028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic potential of oral factor Xa inhibitors.
    Hylek EM
    N Engl J Med; 2010 Dec; 363(26):2559-61. PubMed ID: 21175319
    [No Abstract]   [Full Text] [Related]  

  • 24. Venous thromboembolism after total hip arthroplasty and total knee arthroplasty: current and future perspectives. Epilogue.
    Merli G
    Am J Manag Care; 2011 Feb; 17(1 Suppl):S33. PubMed ID: 21548181
    [No Abstract]   [Full Text] [Related]  

  • 25. Rivaroxaban: a review of its use for the prophylaxis of venous thromboembolism after total hip or knee replacement surgery.
    Duggan ST
    Am J Cardiovasc Drugs; 2012 Feb; 12(1):57-72. PubMed ID: 22272729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New oral anticoagulant drugs: dabigatran, rivaroxaban and apixaban. Present and future].
    Dumont B; Faille D; Ajzenberg N
    Med Sci (Paris); 2011 May; 27(5):493-500. PubMed ID: 21609670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of rivaroxaban after total hip or total knee arthroplasty.
    Kwong LM
    Am J Manag Care; 2011 Feb; 17(1 Suppl):S22-6. PubMed ID: 21517652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of rivaroxaban for thromboprophylaxis following lower limb surgery: an update.
    Goff T; Kontakis G; Giannoudis PV
    Expert Opin Drug Saf; 2011 Sep; 10(5):687-96. PubMed ID: 21406027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Summary and perspectives. Rivaroxaban].
    Albaladejo P
    Ann Fr Anesth Reanim; 2008 Dec; 27 Suppl 3():S28-31. PubMed ID: 19185785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rivaroxaban for thromboprophylaxis.
    Lippi G; Franchini M; Targher G
    N Engl J Med; 2008 Nov; 359(20):2174; author reply 2175-6. PubMed ID: 19009674
    [No Abstract]   [Full Text] [Related]  

  • 31. Apixaban versus enoxaparin for thromboprophylaxis after hip replacement.
    Lassen MR; Gallus A; Raskob GE; Pineo G; Chen D; Ramirez LM;
    N Engl J Med; 2010 Dec; 363(26):2487-98. PubMed ID: 21175312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticoagulation: a GP primer on the new oral anticoagulants.
    Brieger D
    Aust Fam Physician; 2014 May; 43(5):254-9. PubMed ID: 24791763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of anti-factor Xa monitoring in surgical patients receiving prophylactic doses of enoxaparin for venous thromboembolism prophylaxis.
    Pannucci CJ; Prazak AM; Scheefer M
    Am J Surg; 2017 Jun; 213(6):1143-1152. PubMed ID: 27692434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of rivaroxaban on the complications of surgery after total hip or knee replacement: results from the RECORD programme.
    Lassen MR; Gent M; Kakkar AK; Eriksson BI; Homering M; Berkowitz SD; Turpie AG
    J Bone Joint Surg Br; 2012 Nov; 94(11):1573-8. PubMed ID: 23109641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The importance of VTE prevention after orthopaedic surgery.
    Becker RC
    Lancet; 2009 May; 373(9676):1661-2. PubMed ID: 19411101
    [No Abstract]   [Full Text] [Related]  

  • 36. Rivaroxaban, an oral, direct factor Xa inhibitor: a new option for thromboprophylaxis.
    Kwong LM
    Orthopedics; 2012 Nov; 35(11):919; discussion 919. PubMed ID: 23127435
    [No Abstract]   [Full Text] [Related]  

  • 37. New oral anticoagulants show promise.
    Hampton T
    JAMA; 2006 Feb; 295(7):743-4. PubMed ID: 16478891
    [No Abstract]   [Full Text] [Related]  

  • 38. NOACs for thromboprophylaxis in medical patients.
    Cohen AA; Rider T
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):183-90. PubMed ID: 23953906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Rivaroxaban (Xarelto): efficacy and safety].
    Rosencher N; Arnaout L; Chabbouh T; Bellamy L
    Ann Fr Anesth Reanim; 2008 Dec; 27 Suppl 3():S22-7. PubMed ID: 19185784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rivaroxaban for the prevention of venous thromboembolism following major orthopedic surgery: the RECORD trials.
    Ageno W
    Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):569-76. PubMed ID: 19505271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.